ExodusPoint Capital Management LP Makes New Investment in Xylem Inc. $XYL

ExodusPoint Capital Management LP bought a new position in Xylem Inc. (NYSE:XYL) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 131,006 shares of the industrial products company’s stock, valued at approximately $17,840,000.

Several other large investors also recently added to or reduced their stakes in XYL. Knuff & Co LLC bought a new stake in Xylem in the third quarter worth approximately $27,000. Board of the Pension Protection Fund bought a new stake in Xylem in the fourth quarter worth approximately $27,000. Commonwealth Retirement Investments LLC bought a new stake in Xylem in the fourth quarter worth approximately $27,000. Wexford Capital LP bought a new stake in Xylem in the third quarter worth approximately $27,000. Finally, Ramirez Asset Management Inc. grew its position in Xylem by 100.0% in the third quarter. Ramirez Asset Management Inc. now owns 200 shares of the industrial products company’s stock worth $30,000 after acquiring an additional 100 shares in the last quarter. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

NYSE XYL opened at $112.19 on Wednesday. The company has a current ratio of 1.46, a quick ratio of 1.10 and a debt-to-equity ratio of 0.13. The company has a fifty day simple moving average of $115.39 and a 200 day simple moving average of $126.83. The company has a market cap of $26.67 billion, a P/E ratio of 27.91, a P/E/G ratio of 1.58 and a beta of 1.04. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27.

Xylem (NYSE:XYL) last announced its quarterly earnings data on Tuesday, April 28th. The industrial products company reported $1.12 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.09 by $0.03. The business had revenue of $2.13 billion for the quarter, compared to the consensus estimate of $2.11 billion. Xylem had a net margin of 10.79% and a return on equity of 11.26%. Xylem’s quarterly revenue was up 2.7% on a year-over-year basis. During the same quarter last year, the company posted $1.03 earnings per share. Xylem has set its FY 2026 guidance at 5.350-5.600 EPS. On average, sell-side analysts predict that Xylem Inc. will post 5.51 EPS for the current year.

Xylem announced that its Board of Directors has authorized a share repurchase plan on Wednesday, February 25th that authorizes the company to repurchase $1.50 billion in shares. This repurchase authorization authorizes the industrial products company to purchase up to 4.8% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s board of directors believes its shares are undervalued.

Xylem Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th will be issued a $0.43 dividend. The ex-dividend date of this dividend is Thursday, May 28th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s dividend payout ratio is 42.79%.

Insiders Place Their Bets

In other Xylem news, CAO Geri-Michelle Mcshane sold 4,269 shares of the stock in a transaction on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the completion of the sale, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This represents a 54.22% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Jerome A. Peribere purchased 1,210 shares of Xylem stock in a transaction on Monday, May 4th. The stock was bought at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the acquisition, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. This trade represents a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.32% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several analysts have commented on the stock. Weiss Ratings downgraded shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Jefferies Financial Group reissued a “hold” rating and issued a $130.00 target price (down from $140.00) on shares of Xylem in a research report on Tuesday, March 31st. UBS Group boosted their target price on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research report on Wednesday, April 29th. JPMorgan Chase & Co. decreased their target price on shares of Xylem from $170.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, April 16th. Finally, Citigroup decreased their price objective on shares of Xylem from $174.00 to $168.00 and set a “buy” rating for the company in a report on Wednesday, April 29th. Seven analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. Based on data from MarketBeat.com, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $152.77.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.